Request Processed
Your registration request has been processed. We will contact you soon.
Register
First name
Last name
Email
Company
Toggle navigation
Toggle navigation
Login
Register
About
Contact Us
1
2
3
4
5
…
Next ›
Last »
FDA Protocol Deviation Draft Guidance Urges Patient-Friendly Trial Designs To Minimize Deviations, Offers Examples Of “Important” Deviations
December 31, 2024
ODAC “Point/Counterpoint” Shared Briefing Document Formalized Via Draft Guidance; FDA Indicates Sponsor Chooses Approach, Invites Requests For Non-Oncology Products
December 31, 2024
Prevision Policy Clips | FDA Finalizes Advanced Manufacturing Technology Designation Program Guidance
December 31, 2024
“ACNU” Nonprescription Drug Safe Use Rule Finalized By FDA; Simultaneous Rx Marketing Would Be Permitted, If Rule Survives Trump Transition And Judicial Review
December 30, 2024
Prevision Policy Clips | FDA Shutdown Averted, But Pediatric PRV Program In Limbo
December 30, 2024
Prevision Policy Alert: FDA Shutdown Averted, But Pediatric PRV Program In Limbo
December 23, 2024
Prevision Policy Clips | Government Shutdown Clock Is Ticking: House Again Fails To Pass A Continuing Resolution
December 20, 2024
FDA Drug Shortage Provisions Left Out Of Proposed PAHPA Reauthorization Plan; “Lame Duck” Uncertainty Jeopardizes Prospects For Program
December 19, 2024
Prevision Policy Clips | “Lame Duck” Reset: Trump, “DOGE” Torpedo Bipartisan Continuing Resolution
December 19, 2024
Commissioner Califf’s Message On Setting R&D Priorities: Leave FDA Out Of It; National Academy Event Is Forum For Outgoing Commissioner To Reflect, Reiterate Key Themes
December 18, 2024
Prevision Policy Clips | Principal Deputy Commissioner Bumpus Leaving FDA at End of Year
December 18, 2024
End-Of-Year Christmas Tree: SUPPORT, PAHPA And PRV Reauthorizations Make It Into Spending Bill; PBM Reforms Include “De-Linking” Policy, “100%” Rebate Passthroughs
December 18, 2024
Patient Experience Data Needs More Thoughtful Consideration By Sponsors, FDA Says: Workshop Offers Advice On How To Use Available Methods
December 17, 2024
Prevision Policy Clips | HHS Nominee Robert F. Kennedy Jr. Goes To Capitol Hill This Week
December 17, 2024
RSV Pediatric Vaccine Research Should Continue Despite Moderna Setback, “Long Shadow” Of Safety Fears, FDA Committee Agrees; Sanofi May Have Best Prospects
December 16, 2024
Prevision Policy Clips | SUPPORT Act, PAHPA Reauthorizations And PBM Reforms
December 16, 2024
Prevision Policy Clips | Intercept’s Ocaliva Liver Safety Warning From FDA Is Latest Step Short Of Withdrawal
December 13, 2024
CDER’s Newest Sub-Center: Center for Real-World Evidence Innovation (CCRI) Aims To Promote “Efficiency And Consistency” On RWE Policy
December 12, 2024
FDA In “First Stages” Of Reconsidering Black Box For Antipsychotics In Dementia-Related Psychosis; Nuplazid and Rexulti Are Focus Of Discussions
December 12, 2024
Prevision Policy Clips | Lilly CEO Ricks Says Trump Administration Will Push Policy To Raise Drug Prices Abroad
December 12, 2024
GenAI: FDA Would Like To Work With Collaborative Groups On Access To Foundational Data; Clinical Outcome Benefits Remain Key
December 11, 2024
Prevision Policy Clips | GLP-1 Agonist Value Extolled By Elon Musk
December 11, 2024
Prevision Policy Clips | House Energy & Commerce Chair Will Be Kentucky Republican Rep. Guthrie
December 10, 2024
The Other Transition: GOP Takes Control Of Senate; Cassidy Will Be Key Figure For Biopharma In 2025, With Ample Turnover From Last GOP Majority
December 9, 2024
Prevision Policy Clips | Pharma’s “Middleman” Message Resonates With President-Elect Trump
December 9, 2024
1
2
3
4
5
…
Next ›
Last »